Society Logo
ME/CFS Australia Ltd
Please Click Here To Donate ME/CFS Australia (SA) Inc
 
Facebook
 
ME/CFS AUSTRALIA (SA) INC

Registered Charity 698

Email:
sacfs@sacfs.asn.au

Mailing address:
PO Box 28,
Hindmarsh,
South Australia 5007

Office:
Suite 506,
North Terrace House,
19 North Terrace,
Hackney, SA, 5069


Phone:
1300 128 339

Office Hours:
Wednesdays, 11am-3pm

ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

Disclaimer

ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
PDF Application Form (PDF, 277KB)
Why become a member?

German Fibromyalgia survey results challenge heavy emphasis on drug therapies

Tuesday 12 June 2012

 

From BMC Musculoskeletal Disorders (via ProHealth):

 

TabletsGerman Fibromyalgia Survey Results Challenge Heavy Emphasis on Drug Therapies

ProHealth.com
May 24, 2012

Article:

German fibromyalgia consumer reports - a cross-sectional survey
- Source: BMC Musculoskeletal Disorders, May 18, 2012

By Winfried Hauser, et al.

[Note: The full text of this article with detailed survey results is available free HERE.]

Abstract:

Background: Consumer surveys provide information on effectiveness and side effects of medical interventions in routine clinical care. A report of fibromyalgia syndrome (FMS) consumers has not been carried out in Europe.

Methods: The study was carried out from November 2010 to April 2011. Participants diagnosed with FMS rated the effectiveness and side effects of pharmacological and non-pharmacological FMS interventions on a 0 to 10 scale, with 10 being most efficacious [helpful].

The questionnaire was distributed by the German League for people with Arthritis and Rheumatism and the German Fibromyalgia Association to their members and to all consecutive FMS patients of nine clinical centers of different levels of care.

Results: 1,661 questionnaires (95% women, mean age 54 years, mean duration since FMS diagnosis 6.8 years) were analyzed.

The most frequently used therapies were self-management strategies, prescription pain medication and aerobic exercise.

The highest average effectiveness was attributed to whole body and local warmth therapies, thermal baths, FMS education and resting.

The highest average side effects were attributed to:

  • Strong opioids,
  • Local cold therapy,
  • Gamma-amino-butyric acid analogues (pregabalin and gabapentin),
  • Tramadol
  • And opioid transdermal systems.

Conclusion: The German fibromyalgia consumer reports:

  • Highlight the importance of non-pharmacological therapies in the long-term management of FMS,
  • And challenge the strong recommendations for drug therapies given by FMS-guidelines.

Source: BMC Musculoskeletal Disorders, May 18, 2012. PMID:22607517, by Hauser W, Jung E, Erbslöh-Möller B, Gesmann M, Kühn-Becker H, Petermann F, Langhorst J, Thoma R, Weiss T, Wolfe F, Winkelmann A. Department Internal Medicine I, Klinikum Saarbrucken, Saarbrucken, Germany. [Email: whaeuser@klinikum-saarbruecken.de]

 

The above, with comments, originally appeared here.

 


 

blog comments powered by Disqus
Previous Previous Page